" Correction of these Criteria in vitro provides a basis for high content screening of novel small molecule therapeutics, A large body of evidence indicates that the Isoflavone molecule Genistien, can permanently modify epigenetic marks in the Gnome"
Novogen have already stated that they do not have the funds to work in this area, they are going to concentrate on their oncology drugs, does anybody here really believe that they will just sit on this stuff for another five years or thereabouts before working on it again when they have the funds available? I personally don't think that will be the case somehow, some sort of collaboration will happen here and I believe that will happen sooner rather than later.
- Forums
- ASX - By Stock
- KZA
- Novogen to announce potential treatment for Facioscapulohumeral Muscular Dystrophy?
Novogen to announce potential treatment for Facioscapulohumeral Muscular Dystrophy?, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug